“…At issue has been the role of governance and the implications of regulation in mediating the debates and managing the associated risks. Various states operating at multiple scales are responding to the opportunities and threats presented by GMOs and the intersection of these dynamics with broader economic, social, and environmental agendas (Freeman et al, 2011;Twardowski and Małyska, 2015;Uchtmann and Nelson, 2000). Although these processes have been anything but linear, often incorporating the shifting positions of industry, the research community, environmental groups, regulators, among others, several authors contend that regulatory measures, often introduced as a response to public and interest group discontent, have generally reduced industrial uncertainty and promoted biotechnology development (Cocklin et al, 2008;Hansen, 2001) by providing billions of dollars in state-provided financial incentives (e.g., tax relief, funding) concentrated among private sector investors and designed to spur innovation (Moretti and Wilson, 2014).…”